Partnering & Licensing

Axela’s business development strategy is to make new tools accessible to commercial partners seeking solutions for their needs in protein and nucleic acid analysis. The versatility and multiplex capabilities of flow through array and diffractive optic technologies make them ideal for unlocking the potential of the latest biomarker discoveries for clinical and biotechnology research. Similar utility exists in agricultural, environmental and basic research markets in addition to novel sample preparation applications. To fully exploit the capabilities of our technologies we are actively seeking new opportunities in:

  • Diagnostics Partnering
  • Technology Licensing
  • OEM and Distribution

Axela works directly with its partners to design customized assay solutions for their specific needs and performance requirements in high throughput and point of use applications.

Please contact Paul Smith directly for information about our development and licensing programs at